Search Results

Filter
  • 1-10 of  374,514 results for ""Fibrosis""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Understanding CFTR Functionality: A Comprehensive Review of Tests and Modulator Therapy in Cystic Fibrosis.

  • Authors : Thakur S; School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Panjab, India.; Ankita

Subjects: Cystic Fibrosis*/Cystic Fibrosis*/Cystic Fibrosis*/drug therapy ; Cystic Fibrosis*/Cystic Fibrosis*/Cystic Fibrosis*/genetics; Humans

  • Source: Cell biochemistry and biophysics [Cell Biochem Biophys] 2024 Mar; Vol. 82 (1), pp. 15-34. Date of Electronic Publication: 2023 Dec 04.Publisher: Humana Press Country of Publication: United States NLM ID: 9701934 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Functional rescue of CFTR in rectal organoids from patients carrying R334W variant by CFTR modulators and PDE4 inhibitor Roflumilast.

  • Authors : Latorre RV; Department of Medicine, University of Verona, Division of General Pathology, Cystic Fibrosis Laboratory D. Lissandrini, Strada le Grazie 8, 37134, Verona, Italy.; Calicchia M

Subjects: Cystic Fibrosis*/Cystic Fibrosis*/Cystic Fibrosis*/genetics ; Cystic Fibrosis*/Cystic Fibrosis*/Cystic Fibrosis*/metabolism ; Phosphodiesterase 4 Inhibitors*/Phosphodiesterase 4 Inhibitors*/Phosphodiesterase 4 Inhibitors*/pharmacology

  • Source: Respiratory investigation [Respir Investig] 2024 May; Vol. 62 (3), pp. 455-461. Date of Electronic Publication: 2024 Mar 27.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101581124 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Nicotinamide phosphoribosyltransferase prompts bleomycin-induced pulmonary fibrosis by driving macrophage M2 polarization in mice.

  • Authors : Chen Y; Department of Pharmacology, School of Basic Medical Sciences, Zhejiang University, Hangzhou, Zhejiang Province, China.; Wang T

Subjects: Nicotinamide Phosphoribosyltransferase*/Nicotinamide Phosphoribosyltransferase*/Nicotinamide Phosphoribosyltransferase*/metabolism ; Bleomycin* ; Macrophages*/Macrophages*/Macrophages*/metabolism

  • Source: Theranostics [Theranostics] 2024 Apr 28; Vol. 14 (7), pp. 2794-2815. Date of Electronic Publication: 2024 Apr 28 (Print Publication: 2024).Publisher: Ivyspring International Publisher Country of Publication: Australia NLM ID: 101552395 Publication Model: eCollection Cited Medium: Internet

Record details

×
Editorial & Opinion

C-reactive protein as a candidate biomarker in fibrotic interstitial lung disease.

  • Authors : Cottin V; Department of Respiratory Medicine, National Reference Centre for Rare Pulmonary Diseases, member of ERN-LUNG, Louis Pradel Hospital, Hospices Civils de Lyon, Lyon, France.; UMR 754, INRAE, Claude Bernard University Lyon 1, Lyon, France.

Subjects: Lung Diseases, Interstitial*/Lung Diseases, Interstitial*/Lung Diseases, Interstitial*/diagnosis ; Lung Diseases, Interstitial*/Lung Diseases, Interstitial*/Lung Diseases, Interstitial*/pathology ; Idiopathic Pulmonary Fibrosis*/Idiopathic Pulmonary Fibrosis*/Idiopathic Pulmonary Fibrosis*/diagnosis

  • Source: Respirology (Carlton, Vic.) [Respirology] 2024 Mar; Vol. 29 (3), pp. 195-198. Date of Electronic Publication: 2024 Jan 31.Publisher: Blackwell Science Country of Publication: Australia NLM ID: 9616368 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Anti-CX3CL1 (fractalkine) monoclonal antibody attenuates lung and skin fibrosis in sclerodermatous graft-versus-host disease mouse model.

  • Authors : Hasegawa T; Department of Dermatology, Division of Medicine, Faculty of Medical Sciences, University of Fukui, Fukui, 910-1193, Japan.; Utsunomiya A

Subjects: Graft vs Host Disease*/Graft vs Host Disease*/Graft vs Host Disease*/drug therapy ; Graft vs Host Disease*/Graft vs Host Disease*/Graft vs Host Disease*/immunology ; Graft vs Host Disease*/Graft vs Host Disease*/Graft vs Host Disease*/pathology

  • Source: Arthritis research & therapy [Arthritis Res Ther] 2024 May 03; Vol. 26 (1), pp. 94. Date of Electronic Publication: 2024 May 03.Publisher: BioMed Central Country of Publication: England NLM ID: 101154438 Publication Model: Electronic Cited Medium: Internet ISSN: 1478-6362

Record details

×
Academic Journal

Qingkailing granule alleviates pulmonary fibrosis by inhibiting PI3K/AKT and SRC/STAT3 signaling pathways.

  • Authors : Li H; Department of Emergency Medicine, Laboratory of Ethnopharmacology, Tissue-Orientated Property of Chinese Medicine Key Laboratory of Sichuan Province, West China School of Medicine, West China Hospital, Sichuan University, Chengdu 610041, China.; Xin G

Subjects: Pulmonary Fibrosis*/Pulmonary Fibrosis*/Pulmonary Fibrosis*/chemically induced ; Pulmonary Fibrosis*/Pulmonary Fibrosis*/Pulmonary Fibrosis*/drug therapy ; Pulmonary Fibrosis*/Pulmonary Fibrosis*/Pulmonary Fibrosis*/metabolism

  • Source: Bioorganic chemistry [Bioorg Chem] 2024 May; Vol. 146, pp. 107286. Date of Electronic Publication: 2024 Mar 13.Publisher: Elsevier Country of Publication: United States NLM ID: 1303703 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Predicting lung function decline in cystic fibrosis: the impact of initiating ivacaftor therapy.

  • Authors : Zhou GC; Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, TN, USA.; Division of Biostatistics & Epidemiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.

Subjects: Cystic Fibrosis*/Cystic Fibrosis*/Cystic Fibrosis*/drug therapy ; Cystic Fibrosis*/Cystic Fibrosis*/Cystic Fibrosis*/physiopathology ; Cystic Fibrosis*/Cystic Fibrosis*/Cystic Fibrosis*/diagnosis

  • Source: Respiratory research [Respir Res] 2024 Apr 27; Vol. 25 (1), pp. 187. Date of Electronic Publication: 2024 Apr 27.Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 101090633 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

L-arginine mitigates bleomycin-induced pulmonary fibrosis in rats through regulation of HO-1/PPAR-γ/β-catenin axis.

  • Authors : Alhakamy NA; Department of Pharmaceutics, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia; Mohamed Saeed Tamer Chair for Pharmaceutical Industries, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia

Subjects: Pulmonary Fibrosis*/Pulmonary Fibrosis*/Pulmonary Fibrosis*/chemically induced ; Pulmonary Fibrosis*/Pulmonary Fibrosis*/Pulmonary Fibrosis*/drug therapy ; Pulmonary Fibrosis*/Pulmonary Fibrosis*/Pulmonary Fibrosis*/metabolism

  • Source: International immunopharmacology [Int Immunopharmacol] 2024 Apr 20; Vol. 131, pp. 111834. Date of Electronic Publication: 2024 Mar 16.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 100965259 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Tetrandrine alleviates pulmonary fibrosis by inhibiting alveolar epithelial cell senescence through PINK1/Parkin-mediated mitophagy.

  • Authors : Chu L; Chronic Airways Diseases Laboratory, Department of Respiratory and Critical Care Medicine, Nanfang Hospital, Southern Medical University, Guangzhou, China.; Zhuo J

Subjects: Alveolar Epithelial Cells* ; Idiopathic Pulmonary Fibrosis*/Idiopathic Pulmonary Fibrosis*/Idiopathic Pulmonary Fibrosis*/chemically induced ; Idiopathic Pulmonary Fibrosis*/Idiopathic Pulmonary Fibrosis*/Idiopathic Pulmonary Fibrosis*/drug therapy

  • Source: European journal of pharmacology [Eur J Pharmacol] 2024 Apr 15; Vol. 969, pp. 176459. Date of Electronic Publication: 2024 Mar 02.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 1254354 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Genetic Testing Goes Beyond Imaging and Histological Evaluation in Pleuroparenchymal Fibroelastosis.

Subjects: Pulmonary Fibrosis*/Pulmonary Fibrosis*/Pulmonary Fibrosis*/diagnostic imaging ; Pulmonary Fibrosis*/Pulmonary Fibrosis*/Pulmonary Fibrosis*/genetics ; Pulmonary Fibrosis*/Pulmonary Fibrosis*/Pulmonary Fibrosis*/complications

  • Source: Lung [Lung] 2024 Apr; Vol. 202 (2), pp. 151-156. Date of Electronic Publication: 2024 Mar 10.Publisher: Springer Verlag Country of Publication: United States NLM ID: 7701875 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
  • 1-10 of  374,514 results for ""Fibrosis""